August 2007
Edited
by:
Dennis Scott BVSc MACVSc
Ethical
Agents Ltd 54 Hobill Ave Wiri PO Box 97-110
SAMC
Ph 09-262-1388
Fax 09-262-1411 Freephone
0800 800-624
email eage@xtra.co.nz website
www.ethicalagents.co.nz
The major focus for this newsletter is a topic that may not, at face value, be that interesting, but nevertheless is of extreme importance to every facet of veterinary surgery. That subject is disinfection in veterinary practice.
While at first look the subject matter is not thought of as ‘sexy’ there has actually been a quiet revolution going on in this field over the last decade with an explosion of technology.
Old concepts of single molecule disinfectants are now totally outmoded and so are the older style of delivery systems such
as complexes with surfactants.
As well as synergy of several actives being the way to go for the future, the concept of molecular engineering (not to be confused with genetic modification) provides some fascinating possibilities in several different endeavours, not just the field of disinfection.
Misinformation, half truths and perceptions predominate in this micro-war where results are not immediately visible to the naked eye.
However, as seen inside, firm science overcomes theory and conjecture
Nanotechnology
New advance in the field of disinfection
At the cutting edge of this science is molecular engineering.
Just as DNA testing revolutionised forensic science molecular engineering has transformed the micro-war.
Is disinfection now a ‘sexy’ title? Well hardly but with the advent of molecular engineering and the buzzword of nanotechnology it certainly is a lot more interesting.
Fluoroquinolones are the drugs of choice for E coli infections and with the rise in frequency of coliform mastitis in NZ it is timely that Marbocyl 10% has had this usage approved by ACVMG. There are better options for gram +ve mastitis,
just as with there are with cephalosporins, but pk/pd modelling shows the superiority of Marbocyl against E coli, and that is why it is the number 1 drug in Europe for this indication.
